Matches in Nanopublications for { ?s ?p "[We evaluated whether dovitinib (TKI258), an inhibitor of FGFR1, FGFR2, and FGFR3, presented antitumor activity in FGFR-amplified breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP698586.RACUyp5XOMDKB4ZzGuQ7nTLdyDaST_IBVmX-XFuBoUKK4130_assertion description "[We evaluated whether dovitinib (TKI258), an inhibitor of FGFR1, FGFR2, and FGFR3, presented antitumor activity in FGFR-amplified breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP698586.RACUyp5XOMDKB4ZzGuQ7nTLdyDaST_IBVmX-XFuBoUKK4130_provenance.
- assertion description "[We evaluated whether dovitinib (TKI258), an inhibitor of FGFR1, FGFR2, and FGFR3, presented antitumor activity in FGFR-amplified breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.